Urinary microRNAs in sepsis function as a novel prognostic marker
- Authors:
- Rui Han
- Wanqiu Li
- Hui Tian
- Yun Zhao
- Hui Zhang
- Wei Pan
- Xianyi Wang
- Linfeng Xu
- Zhongliang Ma
- Zhijun Bao
-
Affiliations: Department of Emergency, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China, Laboratory for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai 200444, P.R. China, Department of Gerontology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China, Laboratory for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai 200444, P.R. China, Department of Gerontology, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China - Published online on: May 26, 2023 https://doi.org/10.3892/etm.2023.12045
- Article Number: 346
-
Copyright: © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
|
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al: Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the global burden of disease study. Lancet. 395:200–211. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al: The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 315:801–810. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Cerceo E, Rachoin JS, Gaughan J and Weisberg L: Association of gender, age, and race on renal outcomes and mortality in patients with severe sepsis and septic shock. J Crit Care. 61:52–56. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Chinai B, Gaughan J and Schorr C: Implementation of the affordable care Act: A comparison of outcomes in patients with severe sepsis and septic shock using the national inpatient sample. Crit Care Med. 48:783–789. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Gong Y, Li D, Cheng B, Ying B and Wang B: Increased neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with severe sepsis or septic shock. Epidemiol Infect. 148(e87)2020.PubMed/NCBI View Article : Google Scholar | |
|
Gazmuri RJ, Añez de Gomez CI, Siddiqui M, Schechtman J and Nadeem AUR: Severe sepsis and septic shock early management bundle risks aiding vasopressor misuse. Crit Care Med. 47(e717)2019.PubMed/NCBI View Article : Google Scholar | |
|
Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD and Singer M: Sepsis Definitions Task Force. Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 315:775–787. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Angus DC, Seymour CW, Coopersmith CM, Deutschman CS, Klompas M, Levy MM, Martin GS, Osborn TM, Rhee C and Watson RS: A framework for the development and interpretation of different sepsis definitions and clinical criteria. Crit Care Med. 44:e113–e121. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Chang JC: Sepsis and septic shock: Endothelial molecular pathogenesis associated with vascular microthrombotic disease. Thromb J. 17(10)2019.PubMed/NCBI View Article : Google Scholar | |
|
Wang T, Zhang X, Liu Z, Yao T, Zheng D, Gan J, Yu S, Li L, Chen P and Sun J: Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia. Genomics. 113:1219–1233. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Hashemian SM, Pourhanifeh MH, Fadaei S, Velayati AA, Mirzaei H and Hamblin MR: Non-coding RNAs and exosomes: Their role in the pathogenesis of sepsis. Mol Ther Nucleic Acids. 21:51–74. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Sungurlu S, Kuppy J and Balk RA: Role of antithrombin III and tissue factor pathway in the pathogenesis of sepsis. Crit Care Clin. 36:255–265. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang H, Feng YW and Yao YM: A profound understanding of the pathogenesis network in sepsis. Zhonghua Yi Xue Za Zhi. 100:881–885. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Shenoy S: Coronavirus (Covid-19) sepsis: Revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality. Inflamm Res. 69:1077–1085. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Nie C, Qian KJ, Wang LQ, Liu F, Zeng ZG, Zhu F, Xia L and Zhan YA: A clinical study on organ protective effect of early high-volume hemofiltration (HVHF) in patients with multiple organ dysfunction syndrome (MODS) complicated by acute kidney injury (AKI). Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 23:605–607. 2011.PubMed/NCBI(In Chinese). | |
|
Erlanger D, Assous MV, Wiener-Well Y, Yinnon AM and Ben-Chetrit E: Clinical manifestations, risk factors and prognosis of patients with Morganella morganii sepsis. J Microbiol Immunol Infect. 52:443–448. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kasahara E and Inoue M: Cross-talk between HPA-axis-increased glucocorticoids and mitochondrial stress determines immune responses and clinical manifestations of patients with sepsis. Redox Rep. 20:1–10. 2015.PubMed/NCBI View Article : Google Scholar | |
|
El-Hefnawy SM, Mostafa RG, El Zayat RS, Elfeshawy EM, Abd El-Bari HM and El-Monem Ellaithy MA: Biochemical and molecular study on serum miRNA-16a and miRNA-451 as neonatal sepsis biomarkers. Biochem Biophys Rep. 25(100915)2021.PubMed/NCBI View Article : Google Scholar | |
|
Fabri-Faja N, Calvo-Lozano O, Dey P, Terborg RA, Estevez MC, Belushkin A, Yesilköy F, Duempelmann L, Altug H, Pruneri V and Lechuga LM: Early sepsis diagnosis via protein and miRNA biomarkers using a novel point-of-care photonic biosensor. Anal Chim Acta. 1077:232–242. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Li Z, Huang B, Yi W, Wang F, Wei S, Yan H, Qin P, Zou D, Wei R and Chen N: Identification of potential early diagnostic biomarkers of sepsis. J Inflamm Res. 14:621–631. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Kyriazopoulou E, Poulakou G and Giamarellos-Bourboulis EJ: Biomarkers in sepsis: Can they help improve patient outcome? Curr Opin Infect Dis. 34:126–134. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Zhang M, Xie M, Wang Y, Li J and Zhou J: Combination value of biomarkers in discriminating adult onset Still's disease and sepsis. Wien Klin Wochenschr. 133:118–122. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Poston JT and Koyner JL: Sepsis associated acute kidney injury. BMJ. 364(k4891)2019.PubMed/NCBI View Article : Google Scholar | |
|
Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, et al: Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study. Intensive Care Med. 41:1411–1423. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Fabbian F, Savriè C, De Giorgi A, Cappadona R, Di Simone E, Boari B, Storari A, Gallerani M and Manfredini R: Acute kidney injury and in-hospital mortality: A retrospective analysis of a nationwide administrative database of elderly subjects in Italy. J Clin Med. 8(1371)2019.PubMed/NCBI View Article : Google Scholar | |
|
Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, et al: Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2:431–439. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Vasilescu C, Dragomir M, Tanase M, Giza D, Purnichescu-Purtan R, Chen M, Yeung SJ and Calin GA: Circulating miRNAs in sepsis-A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis. PLoS One. 12(e0183334)2017.PubMed/NCBI View Article : Google Scholar | |
|
Dumache R, Rogobete AF, Bedreag OH, Sarandan M, Cradigati AC, Papurica M, Dumbuleu CM, Nartita R and Sandesc D: Use of miRNAs as biomarkers in sepsis. Anal Cell Pathol (Amst). 2015(186716)2015.PubMed/NCBI View Article : Google Scholar | |
|
Ahmad S, Ahmed MM, Hasan PMZ, Sharma A, Bilgrami AL, Manda K, Ishrat R and Syed MA: Identification and validation of potential miRNAs, as biomarkers for sepsis and associated lung injury: A network-based approach. Genes (Basel). 11(1327)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Li M, Bao L and Hu P: A case-control study on the relationship between miRNAs single nucleotide polymorphisms and sepsis risk. Medicine (Baltimore). 98(e16744)2019.PubMed/NCBI View Article : Google Scholar | |
|
Reinhart K and Carlet J: Procalcitonin-a new marker of severe infection and sepsis. Intensive Care Med. 26 (Suppl 2)(S145)2000.PubMed/NCBI View Article : Google Scholar | |
|
Stark A, Brennecke J, Russell RB and Cohen SM: Identification of Drosophila MicroRNA targets. PLoS Biol. 1(E60)2003.PubMed/NCBI View Article : Google Scholar | |
|
Xu P, Vernooy SY, Guo M and Hay BA: The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol. 13:790–795. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Jeker LT and Bluestone JA: MicroRNA regulation of T-cell differentiation and function. Immunol Rev. 253:65–81. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D, Hastings ML and Duelli DM: Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One. 5(e13515)2010.PubMed/NCBI View Article : Google Scholar | |
|
Mir R, Elfaki I, Khullar N, Waza AA, Jha C, Mir MM, Nisa S, Mohammad B, Mir TA, Maqbool M, et al: Role of selected miRNAs as diagnostic and prognostic biomarkers in cardiovascular diseases, including coronary artery disease, myocardial infarction and atherosclerosis. J Cardiovasc Dev Dis. 8(22)2021.PubMed/NCBI View Article : Google Scholar | |
|
Gessner I, Fries JWU, Brune V and Mathur S: Magnetic nanoparticle-based amplification of microRNA detection in body fluids for early disease diagnosis. J Mater Chem B. 9:9–22. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Demircan T, Sibai M, Avşaroğlu ME, Altuntaş E and Ovezmyradov G: The first report on circulating microRNAs at Pre- and Post-metamorphic stages of axolotls. Gene. 768(145258)2021.PubMed/NCBI View Article : Google Scholar | |
|
Tan PPS, Hall D, Chilian WM, Chia YC, Mohd Zain S, Lim HM, Kumar DN, Ching SM, Low TY, Md Noh MF and Pung YF: Exosomal microRNAs in the development of essential hypertension and its potential as biomarkers. Am J Physiol Heart Circ Physiol. 320:H1486–H1497. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Cui C and Cui Q: The relationship of human tissue microRNAs with those from body fluids. Sci Rep. 10(5644)2020.PubMed/NCBI View Article : Google Scholar | |
|
Harrill AH and Sanders AP: Urinary MicroRNAs in environmental health: Biomarkers of emergent kidney injury and disease. Curr Environ Health Rep. 7:101–108. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Dos Santos CC, Amatullah H, Vaswani CM, Maron-Gutierrez T, Kim M, Mei SHJ, Szaszi K, Monteiro APT, Varkouhi AK, Herreroz R, et al: Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury. Eur Respir J. 59(2004216)2022.PubMed/NCBI View Article : Google Scholar | |
|
Jiao Y, Zhang T, Zhang C, Ji H, Tong X, Xia R, Wang W, Ma Z and Shi X: Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury. Crit Care. 25(356)2021.PubMed/NCBI View Article : Google Scholar | |
|
Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Scholten D, Frey N, Koch A, Trautwein C, Tacke F and Luedde T: Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One. 8(e54612)2013.PubMed/NCBI View Article : Google Scholar | |
|
Roderburg C, Koch A, Benz F, Vucur M, Spehlmann M, Loosen SH, Luedde M, Rehse S, Lurje G, Trautwein C, et al: Serum levels of miR-143 predict survival in critically Ill patients. Dis Markers. 2019(4850472)2019.PubMed/NCBI View Article : Google Scholar | |
|
Han Y, Dai QC, Shen HL and Zhang XW: Diagnostic value of elevated serum miRNA-143 levels in sepsis. J Int Med Res. 44:875–881. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Zhu C, Chen T and Liu B: Inhibitory effects of miR-25 targeting HMGB1 on macrophage secretion of inflammatory cytokines in sepsis. Oncol Lett. 16:5027–5033. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Moon HG, Yang J, Zheng Y and Jin Y: miR-15a/16 regulates macrophage phagocytosis after bacterial infection. J Immunol. 193:4558–4567. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Wang X, Wang X, Liu X, Wang X, Xu J, Hou S, Zhang X and Ding Y: miR-15a/16 are upreuglated in the serum of neonatal sepsis patients and inhibit the LPS-induced inflammatory pathway. Int J Clin Exp Med. 8:5683–5690. 2015.PubMed/NCBI | |
|
Arroyo AB, Águila S, Fernández-Pérez MP, Reyes-García AML, Reguilón-Gallego L, Zapata-Martínez L, Vicente V, Martínez C and González-Conejero R: miR-146a in cardiovascular diseases and sepsis: An additional burden in the inflammatory balance? Thromb Haemost. 121:1138–1150. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Pfeiffer D, Roßmanith E, Lang I and Falkenhagen D: miR-146a, miR-146b, and miR-155 increase expression of IL-6 and IL-8 and support HSP10 in an in vitro sepsis model. PLoS One. 12(e0179850)2017.PubMed/NCBI View Article : Google Scholar | |
|
Bai X, Zhang J, Cao M, Han S, Liu Y, Wang K, Han F, Li X, Jia Y, Wang X, et al: MicroRNA-146a protects against LPS-induced organ damage by inhibiting Notch1 in macrophage. Int Immunopharmacol. 63:220–226. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Möhnle P, Hirschberger S, Hinske LC, Briegel J, Hübner M, Weis S, Dimopoulos G, Bauer M, Giamarellos-Bourboulis EJ and Kreth S: MicroRNAs 143 and 150 in whole blood enable detection of T-cell immunoparalysis in sepsis. Mol Med. 24(54)2018.PubMed/NCBI View Article : Google Scholar | |
|
SepNet Critical Care Trials Group. Incidence of severe sepsis and septic shock in German intensive care units: The prospective, multicentre INSEP study. Intensive Care Med. 42:1980–1989. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Baykara N, Akalın H, Arslantaş MK, Hancı V, Çağlayan Ç, Kahveci F, Demirağ K, Baydemir C and Ünal N: Sepsis Study Group. Epidemiology of sepsis in intensive care units in Turkey: A multicenter, point-prevalence study. Crit Care. 22(93)2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhou J, Qian C, Zhao M, Yu X, Kang Y, Ma X, Ai Y, Xu Y, Liu D, An Y, et al: Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China. PLoS One. 9(e107181)2014.PubMed/NCBI View Article : Google Scholar | |
|
Mizuno T, Sato W, Ishikawa K, Shinjo H, Miyagawa Y, Noda Y, Imai E and Yamada K: KDIGO (kidney disease: Improving global outcomes) criteria could be a useful outcome predictor of cisplatin-induced acute kidney injury. Oncology. 82:354–359. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Cui M, Cheng C and Zhang L: High-throughput proteomics: A methodological mini-review. Lab Invest. 102:1170–1181. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Cheng H, Xu JH, Kang XH, Wu CC, Tang XN, Chen ML, Lian ZS, Li N and Xu XL: Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer. J Ovarian Res. 16(75)2023.PubMed/NCBI View Article : Google Scholar | |
|
Hegamyer E, Smith N, Thompson AD and Depiero AD: Treatment of suspected sepsis and septic shock in children with chronic disease seen in the pediatric emergency department. Am J Emerg Med. 44:56–61. 2021.PubMed/NCBI View Article : Google Scholar | |
|
D'Onofrio V, Meersman A, Vijgen S, Cartuyvels R, Messiaen P and Gyssens IC: Risk factors for mortality, intensive care unit admission, and bacteremia in patients suspected of sepsis at the emergency department: A prospective cohort study. Open Forum Infect Dis. 8(ofaa594)2020.PubMed/NCBI View Article : Google Scholar | |
|
Barichello T, Generoso JS, Singer M and Dal-Pizzol F: Biomarkers for sepsis: More than just fever and leukocytosis-a narrative review. Crit Care. 26(14)2022.PubMed/NCBI View Article : Google Scholar | |
|
Nassar FJ, Msheik ZS, Itani MM, Helou RE, Hadla R, Kreidieh F, Bejjany R, Mukherji D, Shamseddine A, Nasr RR and Temraz SN: Circulating miRNA as biomarkers for colorectal cancer diagnosis and liver metastasis. Diagnostics (Basel). 11(341)2021.PubMed/NCBI View Article : Google Scholar | |
|
Smolarz M and Widlak P: Serum exosomes and their miRNA load-a potential biomarker of lung cancer. Cancers (Basel). 13(1373)2021.PubMed/NCBI View Article : Google Scholar | |
|
Wang M, Zheng S, Li X, Ding Y, Zhang M, Lin L, Xu H, Cheng Y, Zhang X, Xu H and Li S: Integrated analysis of lncRNA-miRNA-mRNA ceRNA network identified lncRNA EPB41L4A-AS1 as a potential biomarker in non-small cell lung cancer. Front Genet. 11(511676)2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu S, Liu C, Wang Z, Huang J and Zeng Q: microRNA-23a-5p acts as a potential biomarker for sepsis-induced acute respiratory distress syndrome in early stage. Cell Mol Biol (Noisy-le-grand). 62:31–37. 2016.PubMed/NCBI | |
|
Bukauskas T, Kairytė M, Mickus R, Puleikytė L and Macas A: Values of circulating molecular biomarkers (microRNAs) for the evaluation of renal failure during urgent abdominal sepsis anaesthesia. Acta Med Litu. 26:17–24. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Hollen MK, Stortz JA, Darden D, Dirain ML, Nacionales DC, Hawkins RB, Cox MC, Lopez MC, Rincon JC, Ungaro R, et al: Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis. Crit Care. 23(355)2019.PubMed/NCBI View Article : Google Scholar | |
|
Benz F, Roderburg C, Vargas Cardenas D, Vucur M, Gautheron J, Koch A, Zimmermann H, Janssen J, Nieuwenhuijsen L, Luedde M, et al: U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Exp Mol Med. 45(e42)2013.PubMed/NCBI View Article : Google Scholar | |
|
Aomatsu A, Kaneko S, Yanai K, Ishii H, Ito K, Hirai K, Ookawara S, Kobayashi Y, Sanui M and Morishita Y: MicroRNA expression profiling in acute kidney injury. Transl Res. 244:1–31. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Zhao W, Zhang Y, Zhang M, Zhi Y, Li X and Liu X: Effects of total glucosides of paeony on acute renal injury following ischemia-reperfusion via the lncRNA HCG18/miR-16-5p/Bcl-2 axis. Immunobiology. 227(152179)2022.PubMed/NCBI View Article : Google Scholar | |
|
Pan W, Zhang J, Hu L and Huang Z: Evaluation value of serum miR-4299 and miR-16-5p in risk stratification of sepsis-induced acute kidney injury. Biomed Res Int. 2022(5165892)2022.PubMed/NCBI View Article : Google Scholar | |
|
Tang B, Li W, Ji T, Li X, Qu X, Feng L, Zhu Y, Qi Y, Zhu C and Bai S: Downregulation of XIST ameliorates acute kidney injury by sponging miR-142-5p and targeting PDCD4. J Cell Physiol. 235:8852–8863. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Reithmair M, Buschmann D, Märte M, Kirchner B, Hagl D, Kaufmann I, Pfob M, Chouker A, Steinlein OK, Pfaffl MW and Schelling G: Cellular and extracellular miRNAs are blood-compartment-specific diagnostic targets in sepsis. J Cell Mol Med. 21:2403–2411. 2017.PubMed/NCBI View Article : Google Scholar |
